Table 1.
Characteristics | Phase 1 | Phase 2 | Combined | χ2 (P-value) |
---|---|---|---|---|
No of patients (%) | 217 (51.1) | 208 (48.9) | 425 (100.0) | 0.6174 (0.535) |
Observer (Frequency [%]) | ||||
1 | 110 (50.7) | 114 (54.8) | 224 (52.7) | 0.722 (0.396) |
2 | 107 (49.3) | 94 (45.2) | 201 (47.3) | |
Median age in monthsc (range) | 8.0 (0.03–185.0) | 6.0 (0.03–185.0) | 7.0 (0.03–185.0) | −0.870a (0.385)b |
Age group (Frequency [% in each phase]) | ||||
Neonates: 0–27 days | 39 (18.8) | 55 (28.5) | 94 (23.5) | 8.060 (0.045)* |
Infants: 28 days–1 year | 124 (59.9) | 99 (51.3) | 223 (55.8) | |
Children: 2–11 years | 35 (16.9) | 36 (18.7) | 71 (17.7) | |
Adolescent: 12–16 years | 9 (4.3) | 3 (1.6) | 12 (3) |
Notes:
z and P-values obtained from the Mann–Whitney U test.
Assuming 1 month is 30 days.
P<0.05.